Korean clinical practice guideline for benign prostatic hyperpla

Abstract

In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medicine and the Korean Continence Society to develop a Korean clinical practice guideline for BPH. The purpose of this clinical practice guideline is to provide current and comprehensive recommendations for the evaluation and treatment of BPH. The committee developed the guideline mainly by adapting existing guidelines and partially by using the de novo method. A comprehensive literature review was carried out primarily from 2009 to 2013 by using medical search engines including data from Korea. Based on the published evidence, recommendations were synthesized, and the level of evidence of the recommendations was determined by using methods adapted from the 2011 Oxford Centre for Evidence-Based Medicine. Meta-analysis was done for one key question and four recommendations. A draft guideline was reviewed by expert peer reviewers and discussed at an expert consensus meeting until final agreement was achieved. This evidence-based guideline for BPH provides recommendations to primary practitioners and urologists for the diagnosis and treatment of BPH in men older than 40 years.

Correlation Analyses of Computed Tomography and Magnetic Resonance Imaging for Calculation of Prostate Volume in Colorectal Cancer Patients with Voiding Problems Who Cannot Have Transrectal Ultrasonography

“…In addition to the autonomic nerve disruption causes, obstructive lower urinary tract-related voiding symptoms are usually associated with enlargement of the prostate in elderly male patients (60-year-old with 60%, 70s with 70%, and 80s with 80%). These patients do not need any postoperative interventional management but benefit from medical therapies for BPH such as alpha-blockers and surgery to reduce a large TPV [10–13]. Accurate prostate volume determination is useful and critical for those patients with BPH.…”

α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines

“…A total of 2,562 articles were obtained in the preliminary searching. After layer-by-layer screening, 22 guidelines were finally included (Cockett et al, 1991;Chang, 1998;Bereczky et al, 2006;Cavalcanti et al, 2006;Hofner, 2007;Zhang et al, 2007;Mcvary et al, 2011;Zhu et al, 2011;Spatafora et al, 2012;Tammela et al, 2012;Chapple, 2015;Gratzke et al, 2015;Wang, 2015;Yeo et al, 2016;Zhang et al, 2016;Homma et al, 2017;Sun et al, 2017;Yu and Gao, 2017;Zhang et al, 2017;Geng, 2018;Gravas et al, 2019;Nickel et al, 2018). The document screening process and results are shown in Figure 1.…”

“…The document screening process and results are shown in Figure 1. Of the 22 included guidelines, 2 were from European urology association (Gratzke et al, 2015;Gravas et al, 2019), eight from China (Zhang et al, 2007;Zhu et al, 2011;Wang, 2015;Zhang et al, 2016;Sun et al, 2017;Yu and Gao, 2017;Zhang et al, 2017;Geng, 2018), while only one from Japan (Homma et al, 2017), Brazil (Cavalcanti et al, 2006), Finland (Tammela et al, 2012), Germany (Hofner, 2007), the United Kingdom (Chapple, 2015), WHO (Cockett et al, 1991), Italy (Spatafora et al, 2012), Malaysia (Chang, 1998), Canada (Nickel et al, 2018), the United States (Mcvary et al, 2011), South Africa (Bereczky et al, 2006), and Korea (Yeo et al, 2016), respectively. The basic characteristics of the included guidelines are shown in Table 1.…”

5-year long-term efficacy of 120-W GreenLight photoselective vaporization of the prostate for benign prostate hyperplasia

“…Nevertheless, surgical treatments should be selected primarily in the cases with refractory urinary retention, renal insufficiency, recurrent urinary tract infections, bladder stones or consistent prostate bleeding. In addition, when the medical treatments was not effective, surgery of BPH could be considered and weighed [ 3 ].…”